Elevance Health (ELV) Change in Acquisitions & Divestments (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $552.0 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $552.0 million, up 30.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 billion (down 0.78% YoY), and the FY2025 annual result was $1.8 billion, down 12.54% from the prior year.
• Change in Acquisitions & Divestments declined to $552.0 million in Q1 2026 per ELV's latest filing, from $576.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $7.1 billion in Q2 2023 and troughed at -$11.6 billion in Q4 2023.
• A 5-year average of $1.1 billion and a median of $552.0 million in 2026 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments soared 215.27% in 2022, then tumbled 484.57% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $3.0 billion in 2022, then plunged by 484.57% to -$11.6 billion in 2023, then jumped by 104.69% to $544.0 million in 2024, then gained by 5.88% to $576.0 million in 2025, then declined by 4.17% to $552.0 million in 2026.
• Business Quant data shows ELV's Change in Acquisitions & Divestments at $552.0 million in Q1 2026, $576.0 million in Q4 2025, and $447.0 million in Q3 2025.